- Home
- SRPT
SRPT
Sarepta Therapeutics Inc. (DE)
as 02-21-2025 4:00pm EST
Upcoming Earnings Alert:
Get ready for potential market movements as Sarepta Therapeutics Inc. (DE) SRPT prepares to release earnings report on 26 Feb 2025.
| Founded: | 1980 | Country: | United States |
| Employees: | N/A | City: | CAMBRIDGE |
| Market Cap: | N/A | IPO Year: | 1997 |
| Target Price: | $174.64 | AVG Volume (30 days): | 809.5K |
| Analyst Decision: | Buy | Number of Analysts: | 22 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $101.15 - $173.25 | Next Earning Date: | 02-26-2025 |
| Revenue: | $1,640,348,000 | Revenue Growth: | 48.45% |
| Revenue Growth (this year): | 53.06% | Revenue Growth (next year): | 68.79% |
Stock Insider Trading Activity of Sarepta Therapeutics Inc. (DE) (SRPT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Wigzell Hans Lennart Rudolf | SRPT | Director | Dec 12 '24 | Sell | $124.84 | 10,500 | $1,310,820.00 | 22,840 | |
| Boor Kathryn Jean | SRPT | Director | Dec 5 '24 | Sell | $125.55 | 1,636 | $205,399.80 | 5,880 |
Latest Sarepta Therapeutics Inc. (DE) News
SRPT Breaking Stock News: Dive into SRPT Ticker-Specific Updates for Smart Investing
Insider Monkey
3 days ago
Is Sarepta Therapeutics, Inc. (SRPT) The Best Fast Growth Stock To Buy Right Now?
Argus Research
4 days ago
SRPT: Lowering target price to $84.00
Zacks
6 days ago
Down -8.52% in 4 Weeks, Here's Why Sarepta Therapeutics (SRPT) Looks Ripe for a Turnaround
MT Newswires
9 days ago
Sarepta Therapeutics Closes $600 Million Revolving Credit Facility
Business Wire
9 days ago
Sarepta Therapeutics Announces Inaugural $600 Million Senior Secured Revolving Credit Facility
Business Wire
11 days ago
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2024 Financial Results
Thomson Reuters StreetEvents
12 days ago
Q1 2025 Arrowhead Pharmaceuticals Inc Earnings Call
MT Newswires
12 days ago
Deutsche Bank Initiates Coverage on Sarepta Therapeutics With Hold Rating, $136 Price Target
Compare SRPT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SRPT Sarepta Therapeutics Inc. (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.